Kratom and the German Health Advertising Act (HWG): What Are You Allowed to Say? - Kratoein

Kratom and German Advertising Law (HWG): What Can You Say?

Anyone who sells, advertises or publishes about kratom products in Germany operates inside a legal framework that draws clear boundaries. One of the most important legal sources here is the Heilmittelwerbegesetz (HWG) – the German act that governs advertising for medicines, medical devices and certain other products.

This article explains the foundations of the HWG and its relevance for kratom – factually and in plain language. It does not constitute legal advice and does not replace consultation with a lawyer.

What is the Heilmittelwerbegesetz?

The Heilmittelwerbegesetz (HWG) is a German federal act in force since 1965 and amended several times since. It regulates advertising for:

  • Medicinal products (both prescription-only and over the counter)
  • Medical devices
  • Procedures, treatments and objects intended for use on sick or suffering people
  • Food supplements and other products, as soon as curative or health-related effects are attributed to them

The central idea: advertising must not tempt anyone into buying a product as a remedy where no scientific basis and no regulatory authorization exist.

Why is the HWG relevant for kratom?

In Germany, kratom is neither an authorized medicinal product nor a medical device. It is sold as a botanical product – with the explicit notice that it is not intended for consumption.

The HWG, however, does not attach only to medicines. It also becomes relevant where statements about a product – irrespective of its official category – suggest health-related or curative effects. The moment a vendor writes that kratom helps with particular complaints or could ease certain conditions, the HWG moves into the foreground.

What is specifically prohibited

Section 3 HWG expressly names misleading advertising as inadmissible. This includes, among other things:

  • Statements that attribute effects to a product which it does not have
  • Statements creating the impression that a product is a medicine or possesses medicinal efficacy
  • Endorsements by physicians or scientists where these are not substantiated
  • Advertising by reference to disease patterns – that is, linking a product directly to a specific illness

For kratom this means in practice: statements such as "helps against pain", "supports withdrawal", "relieves anxiety" or "acts like a natural opioid" are problematic – even when they are phrased as personal accounts.

What is permitted

The HWG does not prohibit every form of communication about kratom. As a rule the following are permitted:

  • Botanical and chemical information – descriptions of the plant, its alkaloids, its origin
  • Factual product information – ingredients, manufacturing methods, laboratory analyses
  • Legal classifications – explanations of the Novel Food Regulation or of the status under the German Narcotics Act (BtMG)
  • Historical and ethnobotanical context – traditional use in Southeast Asia, without promising effects
  • Neutral accounts of research – "one study observed that …" without deriving direct product recommendations from it

The line between information and advertising

One of the hardest questions in practice is where factual information ends and inadmissible advertising begins. The courts have not developed a rigid scheme for it. What decides the matter is the overall impression a statement leaves on the average reader.

A useful test: after reading the text, would an informed reader assume that the product could help them with a health complaint? If so, the boundary drawn by the HWG may already have been crossed – regardless of whether the words "cure" or "effect" appear explicitly.

What this means for sellers in practice

The HWG does not attach to the goods but to the statement. What matters is not what a product is, but what is claimed about it. Anyone who ascribes to a botanical product an effect against complaints turns it, in legal terms, into a medicinal product by presentation under section 2(1) no. 2 AMG – with the consequence that an authorization would be required which does not exist.

In practical terms: botanical, chemical and legal details are admissible. It becomes inadmissible as soon as a link to illnesses, complaints or bodily condition is established – including indirectly, including as a quoted personal account, and including when phrased as a question. For advertising aimed at the general public, section 11 HWG additionally prohibits reproducing case histories and third-party statements that encourage use.

A second point is often overlooked: an editorial piece can be advertising too. What counts is the link to sales, not the format. An informative article that leads into a purchase at the end, or singles out a particular offer, becomes a commercial act as a whole – and every sentence in it is then measured against the stricter standard.

Conclusion

The Heilmittelwerbegesetz is an important limit in the German market for kratom. It protects consumers from misleading health promises and obliges vendors to communicate factually and honestly. For kratom this means: botanical information yes – promises of healing no. Anyone who understands this framework can operate in this market reliably and reputably.

Further reading

Legal notice

This article is for informational purposes only and does not constitute legal advice. Its content is not intended to encourage consumption. Laws may change; the applicable regulations and information from official bodies are authoritative. Image source: https://www.kratoein.com/

Back to blog